RAZADYNE ER Trademark

Trademark Overview

On Tuesday, October 7, 2008, a trademark application was filed for RAZADYNE ER with the United States Patent and Trademark Office. The USPTO has given the RAZADYNE ER trademark a serial number of 77586860. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, May 31, 2019. This trademark is owned by Johnson & Johnson. The RAZADYNE ER trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceutical for the treatment of central nervous system diseases and disorders
razadyne er

General Information

Serial Number77586860
Word MarkRAZADYNE ER
Filing DateTuesday, October 7, 2008
Status800 - REGISTERED AND RENEWED
Status DateFriday, May 31, 2019
Registration Number3622483
Registration DateTuesday, May 19, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2009

Trademark Statements

Disclaimer with Predetermined Text"ER"
Goods and Serviceshuman pharmaceutical for the treatment of central nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 10, 2008
Primary Code005
First Use Anywhere DateTuesday, May 3, 2005
First Use In Commerce DateTuesday, May 3, 2005

Trademark Owner History

Party NameJohnson & Johnson
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Friday, May 31, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, May 31, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 31, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 31, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 26, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, May 19, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 14, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 14, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 31, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 31, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 19, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 3, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 11, 2009NOTICE OF PUBLICATION
Friday, January 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 23, 2009ASSIGNED TO LIE
Thursday, January 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 8, 2009EXAMINERS AMENDMENT MAILED
Wednesday, January 7, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, January 7, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 16, 2008NON-FINAL ACTION MAILED
Monday, December 15, 2008NON-FINAL ACTION WRITTEN
Monday, December 15, 2008ASSIGNED TO EXAMINER
Friday, October 10, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

razadyne system diseases disorders nervous central pharmaceutical treatment human